Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Science Advances|September 13, 2023
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in miceEduard Puente-Massaguer, Kirill Vasilev, Annika Beyer, et al.
Vaccine|April 16, 2024
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sexJose L Martínez, Nicholas Lemus, Tsoi Ying Lai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in miceCarly M Bliss, Alec W Freyn, Tom G Caniels, et al.
NPJ Vaccines|November 17, 2024
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approachIrene González-Domínguez, Eduard Puente-Massaguer, Adam Abdeljawad, et al.
Vaccine|May 31, 2026
BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacySayan Das, Brandon M Tenaglia, Devon Riley, et al.
The Journal of Infectious Diseases|January 3, 2025
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernVictoria Dolange, Stefan Slamanig, Adam Abdeljawad, et al.
Msphere|July 10, 2026
Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvantDevon V Riley, Lauren Baracco, Sayan Das, et al.
Mbio|December 6, 2023
An <i>in vitro</i> experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibodyKristina E Atanasoff, Luca Brambilla, Daniel C Adelsberg, et al.
Molecular Therapy. Nucleic Acids|April 24, 2026
Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in miceIrene González-Domínguez, Marta Boza, Adam Abdeljawad, et al.
Vaccines|December 22, 2020
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 VaccineWeina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Pageof 8